Hailey 24 Fe

Quick links to important sections

Hailey 24 Fe

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hailey 24 Fe

Quick Facts

Property Description
Active Ingredients Norethindrone Acetate (Progestin), Ethinyl Estradiol (Estrogen)
Form Oral Tablet
Pharmacological Class Estrogen and Progestin Combinations
Common Use Pregnancy Prevention (Oral Contraception)
Origin Synthetic Steroids

What Type of Medicine is Hailey 24 Fe?

Hailey 24 Fe is defined as a Combination Oral Contraceptive (COC) tablet, a synthetic hormonal medication taken by the oral route. The drug is classified under the therapeutic group of Estrogen and Progestin Combinations and is clinically recognized for its effectiveness in providing contraception. The singular primary purpose of this prescription-only medicine is to provide reliable, reversible oral contraception for women of reproductive age seeking a daily regimen.

Hailey 24 Fe: Active Ingredients and Monophasic Structure

The active components in Hailey 24 Fe are two synthetic steroids: Norethindrone Acetate, a progestin, and Ethinyl Estradiol, an estrogen. This specific combination formulation is a monophasic oral contraceptive tablet, meaning the dosage of both hormones remains constant across all 24 active tablets in the cycle. This structure is often positioned for patients who may benefit from the extended active intake period of a 24/4 regimen compared to traditional 21/7 schedules.

The product includes four non-hormonal tablets containing Ferrous Fumarate (iron). The inclusion of this iron component serves solely to support adherence to the continuous 28-day routine and does not serve a primary therapeutic or contraceptive purpose. This structural detail supports the efficacy of adherence-focused packaging designs.

Regulatory References

  1. FDA Drug Label for Hailey 24 Fe
  2. Birth Control Pills Information (MedlinePlus)

What side effects are possible with Hailey 24 Fe?

Adverse Reaction Scope

Category Description
Key adverse reaction categories Side effects are categorized by their statistical frequency and by the affected System-Organ Class (SOC), such as Vascular Disorders and Reproductive System Disorders.
Frequency classification Officially documented effects are classified, ranging from Very Common (e.g., abnormal uterine bleeding or spotting) to Common (e.g., headache, nausea, breast tenderness, mood changes, weight gain) to Rare (e.g., serious thromboembolic events).
System-organ classes involved Reactions are documented across various systems, including Vascular, Gastrointestinal, Nervous System, Reproductive System and Breast, Hepatobiliary, and Metabolism and Nutrition disorders.
Serious adverse reactions The most significant risks documented in regulatory labeling are Thromboembolic Events, which include Deep Vein Thrombosis (DVT), Pulmonary Embolism, Myocardial Infarction, and Stroke. The potential for Hepatic Neoplasia (liver tumors) is also noted.
Population-specific safety considerations The label specifies an elevated risk of serious cardiovascular events for smokers, particularly those over the age of 35. The medicine is formally contraindicated in women with severe hepatic impairment or a history of specific thromboembolic or vascular conditions.
Dose- or exposure-related patterns Abnormal uterine bleeding (spotting) is noted to occur more frequently during the first few cycles of use. The risk of Venous Thromboembolism (VTE) is highest during the first year of initial use and when re-starting after a break of four or more weeks.

Safety Classifications (High-Level)

Classification Aspect Description
Regulatory frequency framework used Safety data is presented using the standardized classification of frequencies (e.g., Very Common, Common) found in government regulatory documentation.
Safety-related restrictions or limitations Absolute contraindications apply to patients with a history of thromboembolic disorders, known thrombophilias, uncontrolled hypertension, and known or suspected hormone-sensitive malignancies.
Context-of-use safety notes The official label contains notes detailing circumstances that warrant immediate discontinuation, such as the development of signs of thromboembolism or a sustained, significant elevation in blood pressure.

Connection to the Overall Safety Profile

The official safety information structures risk by distinguishing between common, expected effects and rare, clinically serious vascular risks. This regulatory framework defines absolute restrictions for specific high-risk individuals, ensuring that the most serious potential events, such as thromboembolic disorders, are formally emphasized and linked to strict safety constraints.

Overdose and Emergency Response

The official regulatory profile for an overdose of Hailey 24 Fe is characterized by the distinct toxicological risks associated with the active hormonal components and the non-hormonal Ferrous Fumarate (iron) tablets.

Feature Regulatory Statement
Documented Overdose Presentations Overdosage of the active hormonal tablets (norethindrone acetate/ethinyl estradiol) may manifest as nausea and withdrawal bleeding in females.
Physiological Systems Affected Gastrointestinal changes (nausea) from the hormones and the potential for fatal poisoning from the iron component; Reproductive system (bleeding) from hormonal overexposure.
Exposure-Related Factors Accidental overdose of iron-containing products is explicitly cited by regulators as a leading cause of fatal poisoning.
Population-Specific Overdose Notes The risk of fatal poisoning is highlighted for children under 6 who ingest the iron tablets. Accidental ingestion of the hormonal tablets by children is reported with no serious ill effects.
When Immediate Medical Help Is Required Immediate medical help is mandated in the case of accidental overdose of iron-containing products.
Overdose Classifications (High-Level) Regulatory Basis
Hormonal Component Severity Classified as having no serious ill effects reported from overdosage.
Iron Component Severity Classified as carrying a risk of fatal poisoning in children.

Official Overdose Statements

The hormonal component overdose is characterized by low toxicity, with documented manifestations limited to non-serious effects, and no specific antidote is specified. The regulatory label explicitly requires that users call a doctor or poison control center immediately if accidental overdose of the iron-containing tablets is suspected. Management of overdosage is generally limited to symptomatic and supportive treatment.

Therapeutic Uses of Hailey 24 Fe

What Hailey 24 Fe Treats: Main Uses and Benefits

Hailey 24 Fe is a combined oral contraceptive that is relevant for easing certain symptomatic discomforts, with its core purpose being symptomatic support for pregnancy prevention. Combinations of ethinyl estradiol and norethindrone are also commonly used to help manage other types of symptoms related to the reproductive cycle.


The primary therapeutic benefit of this medication is offering reversible protection against pregnancy for women of reproductive age, establishing an accepted means of family planning. Beyond contraception, the medication is relevant for clinical situations marked by symptoms that interfere with daily functioning, including the burden of heavy menstrual bleeding (menorrhagia), severe menstrual cramping (dysmenorrhea), and moderate acne vulgaris.

It is applied in addressing conditions presenting with systemic or localized discomfort, and the overall benefit provides supportive relief when symptoms interfere with routine activities. The medication supports efforts to manage cycle fluctuations, which helps maintain a sense of stability when symptoms are more noticeable.

Quick Fact: Relief for Cyclical Discomfort
Symptom Domains Addressed Painful periods, heavy bleeding, irregular cycles, moderate acne
Primary Benefit Reversible protection for family planning
Secondary Benefit Supports functional stability during symptomatic phases

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Hailey 24 Fe?

Hailey 24 Fe is a prescription combined oral contraceptive indicated for use by women of reproductive age to prevent pregnancy. Eligibility is strictly defined by regulatory criteria that manage the risks associated with estrogen and progestin therapy.

Eligibility Status Description (Based on Regulatory Labeling)
Approved Use Females of reproductive age, including postpubertal adolescents.
Not Indicated Postmenopausal women and children before the onset of menstruation (menarche).

Absolute Contraindications (Who Must Not Use)

Use of Hailey 24 Fe is strictly prohibited in patients with certain conditions due to the risk of serious adverse events:

  • Vascular/Thrombotic Risk: History of deep vein thrombosis, stroke, coronary artery disease, or other thromboembolic disorders or hypercoagulopathies.
  • Smoking and Age: Women over 35 years of age who smoke.
  • Cancer: Current or history of breast cancer or other hormone-sensitive cancers.
  • Liver Disease: Presence of liver tumors or severe liver disease (e.g., decompensated cirrhosis).
  • Pregnancy: Women who are or may be pregnant.

Conditional eligibility also applies, such as starting no earlier than 4 weeks after delivery (if not breastfeeding) and discontinuing the medicine before and after major surgery or prolonged immobilization.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines officially documented interaction patterns based on government regulatory labeling.

Classification Interaction Description
Formal Contraindication Co-administration is contraindicated with Hepatitis C medicinal products containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir, due to the risk of elevated liver enzymes.
Population-Specific Restriction The oral contraceptive is contraindicated for females over 35 years of age who smoke due to a heightened risk of serious cardiovascular events.

Pharmacokinetic and Substance Interactions

Interactions involving the hormonal components are primarily based on pharmacokinetic alteration. Strong CYP3A4 inducers, such as rifampin and certain anticonvulsants (e.g., phenytoin, carbamazepine), are documented to decrease the plasma concentrations of norethindrone and ethinyl estradiol, potentially reducing contraceptive effectiveness. The herbal product St. John’s wort also functions as a CYP3A4 inducer, and its use is a noted restriction.

Conversely, substances like atorvastatin, ascorbic acid (Vitamin C), and acetaminophen have been reported in official documents to increase the exposure of the hormones in the bloodstream. The iron component (Ferrous Fumarate) in the inactive tablets may decrease the absorption of co-administered medicines, including quinolone antibiotics and thyroid hormones.

Timing and Procedural Constraints

The regulatory profile mandates specific timing constraints related to systemic thrombosis risk: the medication must be stopped at least four weeks before and through two weeks after major surgery or prolonged immobilization. For postpartum use, initiation must be no earlier than four weeks after delivery in non-breastfeeding women.

Mechanism of Action

Central Hypothalamic-Pituitary-Ovarian (HPO) Suppression

This mechanism involves the sustained, combined action of Norethindrone and Ethinyl Estradiol, which act as agonists at the Progesterone and Estrogen Receptors. This continuous receptor activation generates a negative feedback signal primarily targeting the pituitary gland. This signaling inhibits the secretion of the gonadotropins (FSH and LH), interrupting the physiological cascade required for ovarian function. This central suppression consequently supports the arrest of follicular development and blocks the necessary LH surge, resulting in anovulation (the non-release of an ovum).

Peripheral Tissue Modulation

Secondary mechanistic effects occur locally in the lower reproductive tract. Norethindrone modulates the secretory activity of the cervical glands and the morphology of the endometrium. The resulting physiological change is the formation of a thick, highly viscous cervical mucus that reduces sperm transport. Simultaneously, the uterine lining develops structural changes. The entire mechanism is dependent on the maintenance of constant steroid concentrations, as any interruption compromises the integrity of the negative feedback loop.

Dosage and Administration Information

Hailey 24 Fe follows a precise, continuous 28-day oral regimen. The core dosing schedule is one tablet taken daily at the same time each day for 28 consecutive days.


Administration Protocol

The product utilizes a 24/4 cyclic regimen: 24 active tablets containing 1 mg of norethindrone acetate and 20 mcg of ethinyl estradiol, followed by 4 inactive tablets containing ferrous fumarate. The inactive tablets are included solely to support adherence to the daily schedule. Tablets must be consumed in the sequential order directed on the blister pack to maintain the correct cyclic pattern. The medication may be administered without regard to meals.

Initiation and Continuity

A new regimen may be initiated using either the Day 1 Start or the Sunday Start method. If the Sunday Start is chosen, the regimen includes the use of an additional non-hormonal contraceptive method for the first seven days of the first cycle. Each subsequent pack must be started immediately after the last inactive tablet to ensure cycle continuity.

Specific Usage Principles

Specific usage principles apply to various scenarios. For women who have recently given birth, starting the medication is advised no earlier than four weeks after delivery if they are not breastfeeding. Furthermore, the efficacy of this formulation has not been evaluated in women with a body mass index (BMI) greater than 35 kg/m^2. If severe vomiting or diarrhea occurs within three to four hours after taking an active tablet, this event should be handled according to the detailed missed tablet instructions.

Recent Clinical Evidence

Research evidence / Overview of studies for Hailey 24 Fe


Evidence for use in Pregnancy Prevention (Contraception)

Hailey 24 Fe was studied for its role in pregnancy prevention through Randomized Controlled Trials (RCTs) and non-controlled prospective studies. These studies primarily focused on healthy, sexually active women of reproductive age. Researchers examined outcomes related to the 24-day active hormone regimen in comparison to other regimens and evaluated outcomes such as the Pearl Index, which measures the frequency of pregnancies per 100 women-years of use.

Trials reported measurements of the Pearl Index across the observed populations. Studies also described patterns of patient adherence and continuation with the regimen over defined time intervals. The evidence contributes to the broader evidence landscape concerning this method of contraception.


Evidence for use in Moderate Acne Vulgaris

The active ingredients in Hailey 24 Fe was evaluated in research contexts where symptoms may vary in intensity, specifically moderate acne vulgaris. This was evaluated in intermediate-term trials that compared the combined hormonal preparation against an inactive treatment (placebo). The populations studied included postmenarcheal females who had a diagnosis of moderate acne and were also seeking a combined oral contraceptive.

In these trials, researchers examined outcomes linked to inflammatory or irritative states by counting the number of acne lesions and rating overall skin condition using an Investigator’s Global Assessment scale. Studies explored patient-reported outcomes describing perceived discomfort. Research provides insight into short-term changes in symptoms observed in the studies involving these specific active ingredients.


Evidence in Specific Populations and Subgroups

A key limitation documented in the research record is that evidence for contraceptive efficacy remains limited in a specific subgroup. Specifically, data for certain groups remain insufficient because the primary efficacy trials did not include women with a Body Mass Index (BMI) greater than 35 kg/m^2. For women with this characteristic, evidence suggests certainty remains low regarding contraceptive outcomes.


Known Research Gaps and Uncertainties

Despite the established clinical evaluation, certain areas related to the evidence remain uncertain. For the secondary symptomatic uses (acne and cycle-related symptoms), formal regulatory approval is not universally applied to all generic formulations of the 24/4 regimen, even though the active ingredients was studied for these purposes. Evidence quality was observed to vary across studies, and comparative evidence is lacking for certain symptomatic outcomes.

Key Studies & References

  1. Norethindrone Acetate and Ethinyl Estradiol tablets, official FDA Prescribing Information and Labeling (DailyMed)
  2. Comparison of a 24-day regimen of oral contraceptive to a 21-day regimen: effects on bleeding patterns and cycle control

Frequently Asked Questions (FAQ)

Common questions about Hailey 24 Fe (FAQ)

Q: How long does it typically take for Hailey 24 Fe to become fully effective for birth control?

A: Official regulatory documents indicate that the product is generally not considered fully effective as a contraceptive until after the first seven consecutive days of daily active tablet administration in the first cycle. The official protocol for a Sunday start mandates the use of an additional non-hormonal contraceptive method for the first seven days of the first cycle.

Q: Why might a user not experience a 'period' or have very light bleeding on the placebo pills?

A: The mechanism of this medication involves suppressing ovulation and causing changes to the uterine lining, which is the tissue that sheds during a menstrual bleed. This action often results in a lighter or even absent withdrawal bleed during the inactive pill days. This is a common and expected effect of the medication.

Q: What happens if I start a new pack of Hailey 24 Fe a day later than usual?

A: If a new pack is started later than the day immediately following the last inactive tablet, official instructions advise that the medication may not be fully effective. The official instructions indicate that an additional non-hormonal contraceptive method is required until seven consecutive active tablets have been taken to ensure adequate protection.

Q: What should I do if I experience continuous or frequent bleeding after the first few months?

A: While spotting and bleeding are common initially, regulatory labeling notes that unusual changes in bleeding patterns, such as continuous spotting or sudden, very heavy bleeding, should be taken seriously. In such cases, official guidance emphasizes the importance of consulting with a healthcare provider.

Q: Can Hailey 24 Fe affect my sex drive or libido?

A: Changes in libido, or sex drive, have been reported as a postmarketing adverse event, meaning the relationship is not always fully established in initial trials, but it is a known effect. You may notice an increase or decrease in desire while taking this medication.

Q: Does Hailey 24 Fe cause weight changes, and is it usually a gain or loss?

A: According to regulatory information, weight gain is listed as a common adverse reaction observed in clinical studies. Weight decrease and weight fluctuation have also been reported by users, though less frequently.

Q: Is it normal to have persistent headaches or migraines after starting Hailey 24 Fe?

A: Headaches are listed as a common side effect of the medication. Official warnings specify that a significant change in the type or pattern of headaches or migraines warrants evaluation by a healthcare professional.

Q: Does Hailey 24 Fe improve or worsen acne for most users?

A: The active ingredients in Hailey 24 Fe are specifically indicated for the treatment of moderate acne vulgaris. This means the product is officially studied and approved for the purpose of improving acne. While some individuals may report acne as a side effect, the product is primarily used as a treatment for this condition.

Q: Does Hailey 24 Fe offer any protection against sexually transmitted infections (STIs)?

A: No, Hailey 24 Fe is an oral contraceptive and does not offer any protection against sexually transmitted infections (STIs), including HIV infection (AIDS). Non-hormonal methods, such as condoms, are the only way to protect against STIs.

Q: Is Hailey 24 Fe safe to use for women over the age of 35?

A: The medication is strictly contraindicated, or prohibited, for women over 35 years of age who smoke due to a heightened risk of serious cardiovascular events. For non-smokers in this age group, the appropriateness of use is determined by a healthcare provider after a risk-benefit assessment.

Q: Why do some users report more water retention or bloating when starting the pill?

A: Official adverse reaction reports include fluid retention, which may be perceived as swelling in the ankles or feet, and bloating. These are listed as less common side effects of the medication.

Q: Can Hailey 24 Fe cause vision changes or make wearing contact lenses difficult?

A: Regulatory reports note that changes in vision or difficulty wearing contact lenses are possible side effects. If these effects occur, consultation with a healthcare professional is noted in the official guidance.

Q: What is melasma and is it a potential side effect of Hailey 24 Fe?

A: Melasma refers to the development of blotchy, dark spots, usually on the face or exposed skin. Melasma has been reported as a side effect of this medication. The official label notes that avoiding sun exposure and using sun protection may help minimize the risk of melasma.

Q: Are there any long-term health risks associated with using Hailey 24 Fe for many years?

A: Official warnings focus primarily on the first year of use, noting that the risk of serious side effects like blood clots (Venous Thromboembolism or VTE) is highest during this initial period. The product labeling does not specify a separate, unique risk profile for use extending beyond many years.

Q: Does the time of day I take Hailey 24 Fe affect its effectiveness?

A: To ensure maximum effectiveness, official administration instructions require that the pill be taken at the same time every day, ensuring the interval between doses does not exceed 24 hours. The specific time of day you choose (morning or evening) is flexible, as long as the timing is consistent.

Q: Can my appetite increase or decrease while taking Hailey 24 Fe?

A: Changes in appetite, including both an increase or a decrease, are listed among the reported postmarketing adverse events for this medication. This means it is a known effect, though the frequency is not always precisely known.

Q: What is the chance of getting pregnant if a dose of Hailey 24 Fe is missed?

A: The patient information provided with the medication explicitly states that pregnancy is more likely if active pills are missed. Specific instructions for a missed dose, which outline the necessary actions to manage this risk, are detailed in the official documentation.

Q: Does Hailey 24 Fe contain drospirenone, or is it a different progestin?

A: Hailey 24 Fe contains the progestin Norethindrone Acetate along with the estrogen Ethinyl Estradiol. It does not contain the progestin drospirenone.

Q: Is it common to have stomach upset or nausea when first starting Hailey 24 Fe?

A: Nausea is listed as a common adverse reaction in clinical studies, particularly when starting the medication. Official regulatory information suggests that taking the medication after the evening meal or at bedtime may help reduce stomach upset.

Q: Does Hailey 24 Fe cause or worsen feelings of anxiety?

A: Official information lists anxiety as a common side effect that may be experienced while taking the medication. Mood changes are also a commonly reported reaction in regulatory safety profiles.

Q: Are generic versions of Hailey 24 Fe chemically equivalent to the brand name?

A: Hailey 24 Fe is approved as a generic equivalent of the brand-name product Loestrin 24 Fe. This means that, according to the Food and Drug Administration (FDA), it is considered therapeutically equivalent, containing the same active ingredients in the same strength and dosage form.

Q: Can Hailey 24 Fe affect cholesterol or blood sugar levels?

A: Official warnings note that the medication may affect the body’s ability to process carbohydrates, which can alter blood glucose (sugar) levels, particularly in diabetic women. Official guidance emphasizes that women with hyperlipidemia (high cholesterol) should be monitored carefully.

Q: Is it possible for Hailey 24 Fe to affect my blood pressure?

A: Regulatory warnings indicate that this medication may raise blood pressure in some users. For this reason, blood pressure should be monitored regularly. If blood pressure rises significantly and remains high, the official label requires a healthcare provider to assess whether the medication should be discontinued.

How should Hailey 24 Fe be stored and disposed of?

Hailey 24 Fe must be stored at Controlled Room Temperature, officially maintained between 20 C to 25 C (68 F to 77 F). Temporary temperature excursions are permitted between 15 C and 30 C (59 F and 86 F).

Required Environmental Protection

Condition Requirement (Regulatory Basis)
Temperature Store at Controlled Room Temperature.
Handling Protect from excessive heat, light, and moisture.
Container Keep in original packaging (blister card) and in a closed container.
Child Safety Must be kept out of the reach of children due to the iron content.

Disposal

Unused or expired Hailey 24 Fe must be disposed of in accordance with local regulations. Specific guidance for discarding the product may be obtained from a pharmacist or healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hailey 24 Fe found in:

A-Z Index: